August 19, 2020 -- Bio-Techne and Leica Biosystems have announced the automation of RNAscope COVID-19 probes on Bond Rx, Leica's staining platform, for research use only. This gives researchers the ability to automate COVID-19 research protocols, reduce labor, and speed up turnaround times.
Bio-Techne believes that the RNA probes will help researchers gain a greater understanding of the pathogenesis of COVID-19.
Leica's Bond Rx is a flexible, open staining platform that can run RNAscope (in duplex or multiplex) protocols. RNAscope probes are designed to detect SARS-CoV-2 viral RNA, SARS-CoV-2 viral replication sequences, and cellular receptors targeted by the virus such as angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2).
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
